NVG-2089 is a recombinant Fc fusion protein designed to replicate key immunomodulatory functions of IVIg with greater consistency, scalability, and patient convenience Phase 1 data show NVG-2089 was ...
Standard treatment for many autoimmune diseases includes drugs that suppress the immune system. Even when this approach works (and it doesn’t work for everyone), chronic immunosuppression puts ...
Add Yahoo as a preferred source to see more of our stories on Google. ON THIS PAGE Treatment for chronic inflammatory demyelinating polyneuropathy (CIDP) includes IV infusion at a medical clinic, but ...
The “go” decision was reached early, ahead of the company’s second quarter expected timeline. The results from the interim analysis appear stronger than those reported by Sanofi's experimental drug ...
Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...
Immunovant IMVT announced top-line data from a late-stage study of its investigational candidate, batoclimab, for myasthenia gravis (MG) and initial results from Period 1 of a mid-stage study of the ...
Treatment for chronic inflammatory demyelinating polyneuropathy (CIDP) includes IV infusion at a medical clinic, but now you can get a similar treatment through an injection or infusion at home.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results